V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180001894 | 180000247 | null | null | Curative (C) | null | 2021-07-05 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101099763 |
| 180001919 | 180000250 | null | null | null | null | 2020-02-07 | null | null | null | CNS GCT II GERMINOMA - CARBO ETOP | 101225239 |
| 180001931 | 180000253 | null | null | null | null | 2016-09-22 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101296786 |
| 180001946 | 180000254 | null | null | null | null | 2016-04-06 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101303389 |
| 180002012 | 180000261 | null | null | 03 | null | 2018-12-13 | null | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 101275631 |
| 180002031 | 180000264 | null | null | null | null | 2019-04-11 | null | null | null | TRASTUZUMAB | 101142828 |
| 180002042 | 180000266 | null | null | Adjuvant (A) | null | 2017-09-22 | null | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100850419 |
| 180002084 | 180000270 | null | null | Neo-adjuvant (N) | null | 2019-01-13 | null | null | null | FEC | 101584594 |
| 180002116 | 180000273 | null | null | null | null | 2017-07-09 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100535417 |
| 180002122 | 180000275 | null | null | null | null | 2021-03-20 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101063818 |
| 180002138 | 180000278 | null | null | null | null | 2019-06-13 | null | null | null | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 101200445 |
| 180002144 | 180000280 | null | null | null | null | 2018-11-03 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101018743 |
| 180002173 | 180000285 | null | null | null | null | 2016-11-07 | null | null | null | NB HRNBL-1 COJEC IND COURSE B | 100323679 |
| 180002210 | 180000286 | null | null | null | null | 2018-05-05 | null | null | null | CABOZANTINIB | 100947195 |
| 180002215 | 180000289 | null | null | null | null | 2015-11-21 | null | null | null | CNS GCT II GERMINOMA - CARBO ETOP | 101058184 |
| 180002283 | 180000293 | null | null | null | null | 2016-03-14 | null | null | null | CISPLATIN + ETOPOSIDE | 101073421 |
| 180002317 | 180000295 | null | null | Palliative (P) | null | 2020-11-17 | null | null | null | NOT MATCHED | 101698111 |
| 180002344 | 180000297 | null | null | null | null | 2016-11-21 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100478500 |
| 180002346 | 180000299 | null | null | null | null | 2016-12-22 | null | null | null | SORAFENIB | 100544777 |
| 180002351 | 180000301 | null | null | null | null | 2018-05-08 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101016140 |
| 180002450 | 180000310 | null | null | null | null | 2019-03-09 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100188423 |
| 180002461 | 180000312 | null | null | Palliative (P) | null | 2018-11-21 | null | null | null | ABIRATERONE | 100847825 |
| 180002467 | 180000314 | null | null | null | null | 2018-09-24 | null | null | null | DOCETAXEL | 100363898 |
| 180002488 | 180000316 | null | null | null | null | 2019-12-22 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101864757 |
| 180002499 | 180000318 | null | null | null | null | 2017-02-28 | null | null | null | CABOZANTINIB | 101299470 |
| 180002509 | 180000320 | null | null | null | null | 2016-05-23 | null | null | null | CAPECITABINE | 100113754 |
| 180002521 | 180000322 | null | null | null | null | 2018-11-10 | null | null | null | SELPERCATINIB | 100925301 |
| 180002573 | 180000336 | null | null | null | null | 2017-08-29 | null | null | null | CHOP R | 101133827 |
| 180002624 | 180000339 | null | null | null | null | 2018-06-22 | null | null | null | RITUXIMAB | 101825348 |
| 180002636 | 180000340 | null | null | null | null | 2016-03-08 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101247456 |
| 180002641 | 180000343 | null | null | Palliative (P) | null | 2018-12-27 | null | null | null | NOT MATCHED | 101338026 |
| 180002642 | 180000344 | null | null | null | null | 2018-02-23 | null | null | null | TRASTUZUMAB | 101173138 |
| 180002664 | 180000348 | null | null | Adjuvant (A) | null | 2017-02-17 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100117499 |
| 180002681 | 180000350 | null | null | Palliative (P) | null | 2017-08-20 | null | null | null | LOMUSTINE | 100008103 |
| 180002725 | 180000357 | null | null | Adjuvant (A) | null | 2022-05-12 | null | null | null | PEMBROLIZUMAB | 100741796 |
| 180002772 | 180000365 | null | null | null | null | 2017-11-14 | null | null | null | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 101684207 |
| 180002819 | 180000369 | null | null | null | null | 2019-10-12 | null | null | null | EDP + MITOTANE | 100963359 |
| 180002835 | 180000373 | null | null | null | null | 2017-11-02 | null | null | null | CISPLATIN + VINORELBINE | 100474100 |
| 180002878 | 180000376 | null | null | null | null | 2017-06-20 | null | null | null | CAPECITABINE | 100558438 |
| 180002916 | 180000379 | null | null | null | null | 2017-09-05 | null | null | null | MITOTANE | 101686218 |
| 180002938 | 180000380 | null | null | null | null | 2016-08-19 | null | null | null | SELPERCATINIB | 100576004 |
| 180002997 | 180000385 | null | null | null | null | 2017-07-24 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101279895 |
| 180003003 | 180000386 | null | null | null | null | 2017-05-12 | null | null | null | PAZOPANIB | 101684951 |
| 180003041 | 180000391 | null | null | null | null | 2019-11-01 | null | null | null | CISPLATIN + DOXORUBICIN | 101537007 |
| 180003053 | 180000394 | null | null | null | null | 2021-08-10 | null | null | null | HYDROXYCARBAMIDE | 101792840 |
| 180003118 | 180000398 | null | null | null | null | 2017-03-16 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101518143 |
| 180003119 | 180000399 | null | null | null | null | 2018-07-29 | null | null | null | DASATINIB | 100726636 |
| 180003120 | 180000400 | null | null | 03 | null | 2020-10-23 | null | null | null | CISPLATIN + RT | 100932544 |
| 180003150 | 180000407 | null | null | null | null | 2016-10-29 | null | null | null | VANDETANIB | 100759506 |
| 180003151 | 180000408 | null | null | null | null | 2019-04-29 | null | null | null | ABVD | 100496345 |